(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.35%) $91.45
4 days till quarter result
(bmo 2024-05-09)
Expected move: +/- 5.43%
6.38% € 10.00
Live Chart Being Loaded With Signals
Pharming Group N.V., a biopharmaceutical company, develops and commercialize protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs in the United States, Europe, and internationally...
Stats | |
---|---|
Dzisiejszy wolumen | 1 529.00 |
Średni wolumen | 2 782.00 |
Kapitalizacja rynkowa | 692.32M |
EPS | €0 ( 2024-03-14 ) |
Następna data zysków | ( €0.0100 ) 2024-05-09 |
Last Dividend | €0 ( N/A ) |
Next Dividend | €0 ( N/A ) |
P/E | -62.50 |
ATR14 | €0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2004-05-27 | Camden Partners Strategic Fund Ii A Lp | Buy | 5 000 | Stock Option (right to buy) |
INSIDER POWER |
---|
0.00 |
Last 1 transactions |
Buy: 5 000 | Sell: 0 |
Pharming Group N.V. Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
SAGE | 0.858 |
HCAT | 0.852 |
BDSX | 0.844 |
SDC | 0.839 |
PVBC | 0.834 |
ENSC | 0.831 |
FRHC | 0.83 |
OBNK | 0.829 |
SHY | 0.825 |
OPOF | 0.823 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Pharming Group N.V. Finanse
Annual | 2023 |
Przychody: | €245.32M |
Zysk brutto: | €220.10M (89.72 %) |
EPS: | €0 |
FY | 2023 |
Przychody: | €245.32M |
Zysk brutto: | €220.10M (89.72 %) |
EPS: | €0 |
FY | 2022 |
Przychody: | €205.62M |
Zysk brutto: | €188.06M (91.46 %) |
EPS: | €0.210 |
FY | 2021 |
Przychody: | €167.68M |
Zysk brutto: | €149.86M (89.37 %) |
EPS: | €0.210 |
Financial Reports:
No articles found.
Pharming Group N.V.
Pharming Group N.V., a biopharmaceutical company, develops and commercialize protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs in the United States, Europe, and internationally. The company's lead product is Ruconest, a recombinant human C1 esterase inhibitor that is used for the treatment of acute hereditary angioedema. It also engages in the development of rhC1INH for the treatment of pre-eclampsia, acute kidney injury, and COVID-19; leniolisib, a phosphoinositide 3-kinase delta (PI3K delta) to treat patients with activated PI3K delta syndrome; and alpha-glucosidase therapy for the treatment of pompe and fabry diseases. The company has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of hereditary angioedema. Pharming Group N.V. is headquartered in Leiden, the Netherlands.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej